In vitro release study of transdermal delivery systems of progesterone

Drug Development and Industrial Pharmacy

Volumn 24, Issue 2, 1998, Pages 187-191

  Valenta, C ^a   Biebel, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DEXPANTHENOL; EUDRAGIT; LAUROCAPRAM; PROGESTERONE; UREA;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE;

EID: 0031906249     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809085606     Document Type: Article

References (7)

1. M. D. Wang, L. Seippel, R. H. Purdy, and T. Blackstrom, Relationship between symptom severity and steroid variation in women with premenstrual syndrome, J. Clin. Endocrinol. Metab., 81, 1076-1082 (1996).
2. R. D. Toddywala, K. Ulman, P. Walters, and Y. W. Chien, Effect of physicochemical properties of adhesive on the release, skin permeation and adhesiveness of adhesive-type transdermal drug delivery systems containing silicone-based pressure sensitive adhesives, Int. J. Pharm., 76, 77-89 (1991).
3. 2 transport through human skin in vitro, Int. J. Pharm., 53, 13-24 (1989).
4. C. Valenta, and I. Almasi-Szabo, In vitro diffusion studies of ketoprofen transdermal therapeutic systems, Drug Dev. Ind. Pharm., 21, 1799-805 (1995).
5. H. Stricker, In vitro investigation of drug availability in the gastrointestinal tract, Drugs Made Germ., 13, 35-42 (1970).
6. R. Baker, Controlled release: mechanisms and rates, in Controlled Release, Biologically Active Agents (A. C. Tanquari and R. E Lacey, eds.), Plenum, New York, 1974, pp. 23-71.
7. DE 3902013 Al Patent, Germany 1990.